CA-53-TT18_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 1-cyclopropyl-4-[4-[[5-methyl-3-[3-[4-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-5-yl]-1H-pyrazol-1-yl]methyl]-2-pyridinyl]-piperazine, HIF-1 inhibitor;HIF target gene expression suppressor targeting HIF1A (Novartis, 67377767)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/67377767
Similar Terms
Downloads & Tools

Genes

8 genes differentially expressed following the CA-53-TT18_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
PGK1 phosphoglycerate kinase 1 1.13954
DDIT4 DNA-damage-inducible transcript 4 0.637026
EIF4EBP1 eukaryotic translation initiation factor 4E binding protein 1 0.623817
MORF4L2 mortality factor 4 like 2 0.5741
RPL23 ribosomal protein L23 0.389368
TPI1 triosephosphate isomerase 1 0.355438
TMSB10 thymosin beta 10 0.308314
RPL9 ribosomal protein L9 0.204519